Expanding Access to Low Cost Generic Drugs Act
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure that valid generic drugs may enter the market.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2476: Expanding Access to Low Cost Generic Drugs Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-2476/
"S. 2476: Expanding Access to Low Cost Generic Drugs Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2476/.
S. 2476, 115th Cong. (2026), https://openamerica.io/bill/115-S-2476/.
[S. 2476: Expanding Access to Low Cost Generic Drugs Act](https://openamerica.io/bill/115-S-2476/)